10-Q Filing

MOLINA HEALTHCARE, INC. CIK: 1179929 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001179929-20-000111`
Period End Date	20200630
Filing Date	20200731
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	moh-20200630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 86 Cash Flow Statement 79 Stockholders Equity 40 Comprehensive Income 24

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.45B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.30B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.25B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	59.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	62.00M	shares	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$1.95B	USD	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$1.91B	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Receivables	`ReceivablesNetCurrent`	$1.58B	USD	Point-in-time
Receivables	`ReceivablesNetCurrent`	$1.41B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$273.00M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$163.00M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$7.06B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.97B	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$399.00M	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$385.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$164.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$172.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$79.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$87.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$79.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$65.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$99.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$105.00M	USD	Point-in-time
Total assets	`Assets`	$6.79B	USD	Point-in-time
Total assets	`Assets`	$7.88B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.85B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.96B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.96B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.77B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$664.00M	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$865.00M	USD	Point-in-time
Accounts payable, accrued liabilities and other	`AccountsPayableAndAccruedLiabilitiesCurrent`	$876.00M	USD	Point-in-time
Accounts payable, accrued liabilities and other	`AccountsPayableAndAccruedLiabilitiesCurrent`	$502.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$54.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$249.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.27B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.75B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.24B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.81B	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$229.00M	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$231.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$84.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$90.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.88B	USD	Point-in-time
Total liabilities	`Liabilities`	$4.83B	USD	Point-in-time
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 59 million shares at June 30, 2020, and 62 million shares at December 31, 2019	`CommonStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 59 million shares at June 30, 2020, and 62 million shares at December 31, 2019	`CommonStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$166.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$175.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$32.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$4.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.80B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.78B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.00B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.96B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$6.79B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$7.88B	USD	Point-in-time

Income Statement 86 line items

Line Item	Tag	Value	Unit	Period
Premium revenue	`PremiumsEarnedNet`	$4.05B	USD	1 Quarter
Premium revenue	`PremiumsEarnedNet`	$8.00B	USD	2 Qtrs
Premium revenue	`PremiumsEarnedNet`	$4.37B	USD	1 Quarter
Premium revenue	`PremiumsEarnedNet`	$8.68B	USD	2 Qtrs
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$157.00M	USD	1 Quarter
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$307.00M	USD	2 Qtrs
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$248.00M	USD	2 Qtrs
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$110.00M	USD	1 Quarter
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	-	USD	2 Qtrs
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	$71.00M	USD	1 Quarter
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	$137.00M	USD	2 Qtrs
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	-	USD	1 Quarter
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$63.00M	USD	2 Qtrs
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$47.00M	USD	2 Qtrs
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$18.00M	USD	1 Quarter
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$34.00M	USD	1 Quarter
Total revenue	`Revenues`	$4.62B	USD	1 Quarter
Total revenue	`Revenues`	$9.17B	USD	2 Qtrs
Total revenue	`Revenues`	$8.31B	USD	2 Qtrs
Total revenue	`Revenues`	$4.19B	USD	1 Quarter
Medical care costs	`CostOfGoodsAndServicesSold`	$7.31B	USD	2 Qtrs
Medical care costs	`CostOfGoodsAndServicesSold`	$3.60B	USD	1 Quarter
Medical care costs	`CostOfGoodsAndServicesSold`	$6.84B	USD	2 Qtrs
Medical care costs	`CostOfGoodsAndServicesSold`	$3.47B	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$328.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$345.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$662.00M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$630.00M	USD	2 Qtrs
Premium tax expenses	`PremiumTaxExpenses`	$157.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$307.00M	USD	2 Qtrs
Premium tax expenses	`PremiumTaxExpenses`	$110.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$248.00M	USD	2 Qtrs
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	$71.00M	USD	1 Quarter
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	-	USD	1 Quarter
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	$139.00M	USD	2 Qtrs
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	-	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$41.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$47.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$21.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$22.00M	USD	1 Quarter
Other	`OtherCostAndExpenseOperating`	$2.00M	USD	1 Quarter
Other	`OtherCostAndExpenseOperating`	$6.00M	USD	2 Qtrs
Other	`OtherCostAndExpenseOperating`	$2.00M	USD	1 Quarter
Other	`OtherCostAndExpenseOperating`	$5.00M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$7.77B	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$8.47B	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$4.19B	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$3.93B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$698.00M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$424.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$545.00M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$265.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$45.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$22.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$45.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$24.00M	USD	1 Quarter
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$-5.00M	USD	2 Qtrs
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$14.00M	USD	1 Quarter
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$-5.00M	USD	1 Quarter
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$17.00M	USD	2 Qtrs
Total other expenses, net	`NonoperatingIncomeExpense`	$-50.00M	USD	2 Qtrs
Total other expenses, net	`NonoperatingIncomeExpense`	$-29.00M	USD	1 Quarter
Total other expenses, net	`NonoperatingIncomeExpense`	$-8.00M	USD	1 Quarter
Total other expenses, net	`NonoperatingIncomeExpense`	$-28.00M	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$517.00M	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$648.00M	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$395.00M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$257.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$119.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$61.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$123.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$194.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$454.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$196.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$276.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$394.00M	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$6.34	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.15	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$7.65	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$4.72	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.06	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.65	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$6.04	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$7.54	USD	2 Qtrs

Cash Flow Statement 79 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$196.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$394.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$454.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$276.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$41.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$47.00M	USD	2 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-6.00M	USD	2 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-19.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$19.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$10.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$16.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$28.00M	USD	2 Qtrs
Loss (gain) on debt repayment	`GainsLossesOnExtinguishmentOfDebt`	$17.00M	USD	2 Qtrs
Loss (gain) on debt repayment	`GainsLossesOnExtinguishmentOfDebt`	$-5.00M	USD	2 Qtrs
Loss (gain) on debt repayment	`GainsLossesOnExtinguishmentOfDebt`	$-5.00M	USD	1 Quarter
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$7.00M	USD	2 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-1.00M	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$-91.00M	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$174.00M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-18.00M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$157.00M	USD	2 Qtrs
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$106.00M	USD	2 Qtrs
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$-194.00M	USD	2 Qtrs
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$201.00M	USD	2 Qtrs
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$17.00M	USD	2 Qtrs
Accounts payable, accrued liabilities and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$251.00M	USD	2 Qtrs
Accounts payable, accrued liabilities and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-61.00M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-195.00M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-181.00M	USD	2 Qtrs
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$184.00M	USD	2 Qtrs
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-3.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$156.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$749.00M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$1.16B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$670.00M	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$791.00M	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$750.00M	USD	2 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.00M	USD	2 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$45.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$2.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-3.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$38.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-393.00M	USD	2 Qtrs
Proceeds from senior notes offering, net of issuance costs	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$789.00M	USD	2 Qtrs
Proceeds from senior notes offering, net of issuance costs	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	2 Qtrs
Repayment of term loan facility	`RepaymentsOfLinesOfCredit`	-	USD	2 Qtrs
Repayment of term loan facility	`RepaymentsOfLinesOfCredit`	$600.00M	USD	2 Qtrs
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	$453.00M	USD	2 Qtrs
Proceeds from borrowings under term loan facility	`ProceedsFromLinesOfCredit`	$380.00M	USD	2 Qtrs
Proceeds from borrowings under term loan facility	`ProceedsFromLinesOfCredit`	$220.00M	USD	2 Qtrs
Cash paid for partial termination of warrants	`PaymentsForRepurchaseOfWarrants`	$424.00M	USD	2 Qtrs
Cash paid for partial termination of warrants	`PaymentsForRepurchaseOfWarrants`	$30.00M	USD	2 Qtrs
Cash paid for partial settlement of conversion option	`CashPaidForSettlementOfConversionOption`	$27.00M	USD	2 Qtrs
Cash paid for partial settlement of conversion option	`CashPaidForSettlementOfConversionOption`	$473.00M	USD	2 Qtrs
Cash received for partial settlement of call option	`ProceedsFromConvertibleDebt`	$27.00M	USD	2 Qtrs
Cash received for partial settlement of call option	`ProceedsFromConvertibleDebt`	$473.00M	USD	2 Qtrs
Repayment of principal amount of convertible senior notes	`RepaymentsOfConvertibleDebt`	$12.00M	USD	2 Qtrs
Repayment of principal amount of convertible senior notes	`RepaymentsOfConvertibleDebt`	$185.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$27.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-3.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$71.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-362.00M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-599.00M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$858.00M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.93B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.33B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.33B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.93B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
Common stock used for share-based compensation	`StockIssued1`	$8.00M	USD	2 Qtrs
Common stock used for share-based compensation	`StockIssued1`	$7.00M	USD	2 Qtrs
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	2 Qtrs
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	2 Qtrs

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance (in shares)	`SharesOutstanding`	58.60M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	62.10M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	61.90M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	62.10M	shares	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.96B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.74B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.83B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.00B	USD	Point-in-time
Net income	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$196.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$394.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$454.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$276.00M	USD	1 Quarter
Common stock purchases	`StockRepurchasedDuringPeriodValue`	$446.00M	USD	1 Quarter
Termination of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-321.00M	USD	1 Quarter
Termination of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-30.00M	USD	1 Quarter
Termination of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-103.00M	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$8.00M	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$47.00M	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$5.00M	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-19.00M	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$28.00M	USD	2 Qtrs
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$13.00M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$26.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$18.00M	USD	1 Quarter
Ending Balance (in shares)	`SharesOutstanding`	58.60M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	62.10M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	61.90M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	62.10M	shares	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.00B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.74B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.83B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.96B	USD	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$196.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$394.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$454.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$276.00M	USD	1 Quarter
Unrealized investment income	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$62.00M	USD	1 Quarter
Unrealized investment income	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$17.00M	USD	2 Qtrs
Unrealized investment income	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$37.00M	USD	2 Qtrs
Unrealized investment income	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$10.00M	USD	1 Quarter
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$9.00M	USD	2 Qtrs
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$15.00M	USD	1 Quarter
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$4.00M	USD	2 Qtrs
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$2.00M	USD	1 Quarter
Other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$8.00M	USD	1 Quarter
Other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$47.00M	USD	1 Quarter
Other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$5.00M	USD	1 Quarter
Other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-19.00M	USD	1 Quarter
Other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$28.00M	USD	2 Qtrs
Other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$13.00M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$323.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$407.00M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$482.00M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$204.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.